Then, through an extended MR study design, we sought to strengthen the evidence for a causal relation of blood levels of IL-6 pathway components, including IL-6, sIL6R, soluble IL6ST (also called gp130), and CRP (as shown in Figure 2), on COVID-19 outcomes. The gene discussed is IL6R; the disease is COVID-19.